SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Emilie Faggiani, Frederic Naudet, Marcus L.F. Janssen, Yasin Temel, Abdelhamid Benazzouz, Serotonergic neurons mediate the anxiolytic effect of l -DOPA: Neuronal correlates in the amygdala, Neurobiology of Disease, 2018, 110, 20

    CrossRef

  2. 2
    Oluwafemi E. Kale, Olufunsho Awodele, Temitope F. Ogundare, Martins Ekor, Amlodipine, an L-type calcium channel blocker, protects against chlorpromazine-induced neurobehavioural deficits in mice, Fundamental & Clinical Pharmacology, 2017, 31, 3
  3. 3
    Corneliu C. Luca, Gloria Nadayil, Chuanhui Dong, Fatta B. Nahab, Edelle Field-Fote, Carlos Singer, Dalfampridine in Parkinson's disease related gait dysfunction: A randomized double blind trial, Journal of the Neurological Sciences, 2017, 379, 7

    CrossRef

  4. 4
    Xin-Ling Su, Xiao-Guang Luo, Hong Lv, Jun Wang, Yan Ren, Zhi-Yi He, Factors predicting the instant effect of motor function after subthalamic nucleus deep brain stimulation in Parkinson’s disease, Translational Neurodegeneration, 2017, 6, 1

    CrossRef

  5. 5
    Antonio Suppa, Ardian Kita, Giorgio Leodori, Alessandro Zampogna, Ettore Nicolini, Paolo Lorenzi, Rosario Rao, Fernanda Irrera, l-DOPA and Freezing of Gait in Parkinson’s Disease: Objective Assessment through a Wearable Wireless System, Frontiers in Neurology, 2017, 8,

    CrossRef

  6. 6
    Francesco Corallo, Maria Cristina De Cola, Viviana Lo Buono, Giuseppe Di Lorenzo, Placido Bramanti, Silvia Marino, Observational study of quality of life of Parkinson's patients and their caregivers, Psychogeriatrics, 2017, 17, 2
  7. 7
    Manuel Montero-Odasso, Locomotion and Posture in Older Adults, 2017,

    CrossRef

  8. 8
    Philippe Damier, Constance Hammond, Yeheskel Ben-Ari, Bumetanide to Treat Parkinson Disease, Clinical Neuropharmacology, 2016, 39, 1, 57

    CrossRef

  9. 9
    N. Lenfeldt, H. Holmlund, A. Larsson, R. Birgander, L. Forsgren, Frontal white matter injuries predestine gait difficulties in Parkinson's disease, Acta Neurologica Scandinavica, 2016, 134, 3
  10. 10
    Fariborz Rahimi, Angela C. Roberts, Mandar Jog, Patterns and predictors of freezing of gait improvement following rasagiline therapy: A pilot study, Clinical Neurology and Neurosurgery, 2016, 150, 117

    CrossRef

  11. 11
    Izel Tekin, Nurgul Carkaci-Salli, Mechelle M. Lewis, Richard B. Mailman, Xuemei Huang, Kent E. Vrana, The V81M variant of tyrosine hydroxylase is associated with more severe freezing of gait in Parkinson's disease, Parkinsonism & Related Disorders, 2016, 23, 86

    CrossRef

  12. 12
    Shih-Wei Huang, Jia-Wei Lin, Tsan-Hon Liou, Hui-Wen Lin, Cohort study evaluating the risk of hip fracture among patients with dementia in Taiwan, International Journal of Geriatric Psychiatry, 2015, 30, 7
  13. 13
    R. K. Chong, K.-H. Lee, J. Morgan, C. Wakade, Duration of step initiation predicts freezing in Parkinson's disease, Acta Neurologica Scandinavica, 2015, 132, 2
  14. 14
    Ruwei Ou, Xiaoyan Guo, Qianqian Wei, Bei Cao, Jing Yang, Wei Song, Na Shao, Bi Zhao, Xueping Chen, Huifang Shang, Festination in Chinese patients with Parkinson's disease, Clinical Neurology and Neurosurgery, 2015, 139, 172

    CrossRef

  15. 15
    Harini Sarva, Andres Deik, Matthew Carrington Swan, William Lawrence Severt, Freezing of gait after a hemorrhagic stroke can respond to venlafaxine and rivastigmine, Neurology: Clinical Practice, 2015, 5, 3, 267

    CrossRef

  16. 16
    Marion Albares, Stéphane Thobois, Emilie Favre, Emmanuel Broussolle, Gustavo Polo, Philippe Domenech, Philippe Boulinguez, Bénédicte Ballanger, Interaction of Noradrenergic Pharmacological Manipulation and Subthalamic Stimulation on Movement Initiation Control in Parkinson's Disease, Brain Stimulation, 2015, 8, 1, 27

    CrossRef

  17. 17
    Audrey Maillet, Stéphane Thobois, Valérie Fraix, Jérôme Redouté, Didier Le Bars, Franck Lavenne, Philippe Derost, Franck Durif, Bastiaan R. Bloem, Paul Krack, Pierre Pollak, Bettina Debû, Neural substrates of levodopa-responsive gait disorders and freezing in advanced Parkinson's disease: A kinesthetic imagery approach, Human Brain Mapping, 2015, 36, 3
  18. 18
    Takashi Nakamura, Yasuhiro Shimada, Tomoya Takeda, Katsuyuki Sato, Mitsuo Akiba, Haruhiko Fukaya, Organogermanium compound, Ge-132, forms complexes with adrenaline, ATP and other physiological cis-diol compounds, Future Medicinal Chemistry, 2015, 7, 10, 1233

    CrossRef

  19. 19
    Marina Picillo, Raffaele Dubbioso, Rosa Iodice, Alessandro Iavarone, Chiara Pisciotta, Emanuele Spina, Lucio Santoro, Paolo Barone, Marianna Amboni, Fiore Manganelli, Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait, Journal of Neural Transmission, 2015, 122, 11, 1533

    CrossRef

  20. 20
    Sabine Skodda, Steadiness of syllable repetition in early motor stages of Parkinson's disease, Biomedical Signal Processing and Control, 2015, 17, 55

    CrossRef

  21. 21
    Duncan A. A. MacLaren, Joseph A. Santini, Ashley L. Russell, Tamara Markovic, Stewart D. Clark, Deficits in motor performance after pedunculopontine lesions in rats – impairment depends on demands of task, European Journal of Neuroscience, 2014, 40, 8
  22. 22
    Lucia Ricciardi, Bastiaan R. Bloem, Anke H. Snijders, Antonio Daniele, Davide Quaranta, Anna Rita Bentivoglio, Alfonso Fasano, Freezing of gait in Parkinson's disease: The paradoxical interplay between gait and cognition, Parkinsonism & Related Disorders, 2014, 20, 8, 824

    CrossRef

  23. 23
    Yoko Hagino, Shinya Kasai, Masayo Fujita, Susumu Setogawa, Hiroshi Yamaura, Dai Yanagihara, Makoto Hashimoto, Kazuto Kobayashi, Herbert Y Meltzer, Kazutaka Ikeda, Involvement of Cholinergic System in Hyperactivity in Dopamine-Deficient Mice, Neuropsychopharmacology, 2014, 40, 5, 1141

    CrossRef

  24. 24
    Natalia Madalena Rinaldi, Marcelo Pinto Pereira, Priscila Matias Formaggio, Luana Carolina Morais, Lilian Teresa Bucken Gobbi, Positive effects of auditory cue in locomotor pattern of people with Parkinson’s disease (off and on medication), Revista Brasileira de Educação Física e Esporte, 2014, 28, 4, 561

    CrossRef

  25. 25
    Stefania Sgroi, Alain Kaelin-Lang, Christine Capper-Loup, Spontaneous locomotor activity and L-DOPA-induced dyskinesia are not linked in 6-OHDA parkinsonian rats, Frontiers in Behavioral Neuroscience, 2014, 8,

    CrossRef

  26. 26
    Albert Y. Hung, Michael A. Schwarzschild, Treatment of Parkinson’s Disease: What’s in the Non-dopaminergic Pipeline?, Neurotherapeutics, 2014, 11, 1, 34

    CrossRef

  27. 27
    Hiu-Fai Chan, Prashanth L. Kukkle, Marcelo Merello, Shen-Yang Lim, Yu-Yan Poon, Elena Moro, Amantadine improves gait in PD patients with STN stimulation, Parkinsonism & Related Disorders, 2013, 19, 3, 316

    CrossRef

  28. 28
    Shinichi Amano, Ryan T. Roemmich, Jared W. Skinner, Chris J. Hass, Ambulation and Parkinson Disease, Physical Medicine and Rehabilitation Clinics of North America, 2013, 24, 2, 371

    CrossRef

  29. 29
    Corneliu C. Luca, Carlos Singer, Can 4-aminopyridine modulate dysfunctional gait networks in Parkinson's disease?, Parkinsonism & Related Disorders, 2013, 19, 9, 777

    CrossRef

  30. 30
    Vikas Kotagal, Roger L. Albin, Martijn L.T.M. Müller, Robert A. Koeppe, Kirk A. Frey, Nicolaas I. Bohnen, Diabetes is associated with postural instability and gait difficulty in Parkinson disease, Parkinsonism & Related Disorders, 2013, 19, 5, 522

    CrossRef

  31. 31
    Elke Heremans, Alice Nieuwboer, Sarah Vercruysse, Freezing of Gait in Parkinson’s Disease: Where Are We Now?, Current Neurology and Neuroscience Reports, 2013, 13, 6

    CrossRef

  32. 32
    Eliraz Seri-Fainshtat, Zvi Israel, Aner Weiss, Jeffrey M Hausdorff, Impact of sub-thalamic nucleus deep brain stimulation on dual tasking gait in Parkinson’s disease, Journal of NeuroEngineering and Rehabilitation, 2013, 10, 1, 38

    CrossRef

  33. 33
    Sabine Skodda, Julia Lorenz, Uwe Schlegel, Instability of syllable repetition in Parkinson's disease—Impairment of automated speech performance?, Basal Ganglia, 2013, 3, 1, 33

    CrossRef

  34. 34
    Jee Young Lee, Sohee Oh, Jong Min Kim, Ji Sun Kim, Eungseok Oh, Hee-Tae Kim, Beom S. Jeon, Jin Whan Cho, Intravenous amantadine on freezing of gait in Parkinson’s disease: a randomized controlled trial, Journal of Neurology, 2013, 260, 12, 3030

    CrossRef

  35. 35
    David Devos, Caroline Moreau, Kathy Dujardin, Ioav Cabantchik, Luc Defebvre, Regis Bordet, New Pharmacological Options for Treating Advanced Parkinson’s Disease, Clinical Therapeutics, 2013, 35, 10, 1640

    CrossRef

  36. 36
    Moazamehosadat Razavinasab, Ali Shamsizadeh, Mohammad Shabani, Masoud Nazeri, Mohammad Allahtavakoli, Majid Asadi-Shekaari, Saeed Esmaeli-Mahani, Vahid Sheibani, Pharmacological blockade of TRPV1 receptors modulates the effects of 6-OHDA on motor and cognitive functions in a rat model of Parkinson's disease, Fundamental & Clinical Pharmacology, 2013, 27, 6
  37. 37
    Joseph Jankovic, Raja Mehanna, Handbook of Parkinson's Disease, Fifth Edition, 2013,

    CrossRef

  38. 38
    Joseph Jankovic, Raja Mehanna, Handbook of Parkinson’s Disease, 2013,

    CrossRef

  39. 39
    Valerie E. Kelly, Alexis J. Eusterbrock, Anne Shumway-Cook, A Review of Dual-Task Walking Deficits in People with Parkinson's Disease: Motor and Cognitive Contributions, Mechanisms, and Clinical Implications, Parkinson's Disease, 2012, 2012, 1

    CrossRef

  40. 40
    J.E. Westin, M.L.F. Janssen, T.N. Sager, Y. Temel, Automated gait analysis in bilateral Parkinsonian rats and the role of l-DOPA therapy, Behavioural Brain Research, 2012, 226, 2, 519

    CrossRef

  41. 41
    Sarah Vercruysse, Hannes Devos, Liesbeth Munks, Joke Spildooren, Jochen Vandenbossche, Wim Vandenberghe, Alice Nieuwboer, Elke Heremans, Explaining freezing of gait in Parkinson's disease: Motor and cognitive determinants, Movement Disorders, 2012, 27, 13
  42. 42
    Manuel Montero-Odasso, Joe Verghese, Olivier Beauchet, Jeffrey M. Hausdorff, Gait and Cognition: A Complementary Approach to Understanding Brain Function and the Risk of Falling, Journal of the American Geriatrics Society, 2012, 60, 11
  43. 43
    Marianna Amboni, Paolo Barone, Luigi Iuppariello, Ilaria Lista, Riccardo Tranfaglia, Alfonso Fasano, Marina Picillo, Carmine Vitale, Gabriella Santangelo, Valeria Agosti, Alessandro Iavarone, Giuseppe Sorrentino, Gait patterns in parkinsonian patients with or without mild cognitive impairment, Movement Disorders, 2012, 27, 12
  44. 44
    Yoland Smith, Thomas Wichmann, Stewart A Factor, Mahlon R DeLong, Parkinson's Disease Therapeutics: New Developments and Challenges Since the Introduction of Levodopa, Neuropsychopharmacology, 2012, 37, 1, 213

    CrossRef

  45. 45
    Lisa Glasl, Karina Kloos, Florian Giesert, Anne Roethig, Barbara Di Benedetto, Ralf Kühn, Jingzhong Zhang, Ulrich Hafen, Julia Zerle, Andreas Hofmann, Martin Hrabé de Angelis, Konstanze F. Winklhofer, Sabine M. Hölter, Daniela M. Vogt Weisenhorn, Wolfgang Wurst, Pink1-deficiency in mice impairs gait, olfaction and serotonergic innervation of the olfactory bulb, Experimental Neurology, 2012, 235, 1, 214

    CrossRef

  46. 46
    Paramita Chakrabarty, Carolina Ceballos-Diaz, Wen-Lang Lin, Amanda Beccard, Karen Jansen-West, Nikolaus R McFarland, Christopher Janus, Dennis Dickson, Pritam Das, Todd E Golde, Interferon-γ induces progressive nigrostriatal degeneration and basal ganglia calcification, Nature Neuroscience, 2011, 14, 6, 694

    CrossRef

  47. 47
    Michele Poletti, Murat Emre, Ubaldo Bonuccelli, Mild cognitive impairment and cognitive reserve in Parkinson’s disease, Parkinsonism & Related Disorders, 2011, 17, 8, 579

    CrossRef